Limitations in assessing cardiovascular risk of febuxostat in patients with gout and cardiovascular morbidities: comment on the article by Choi et al

Arthritis&Rheumatology, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40838?af=R

Source: Arthritis and Rheumatology - April 11, 2019 Category: Rheumatology Authors: Aryeh M. Abeles, Michael H. Pillinger Tags: Letters Source Type: research